News
Drug and biotech news
Last checked: Nov 20, 2026Source: BioPharma Dive, STAT (pharma), FDA press releases, FDA MedWatch, Drugs@FDA (new approvals), openFDA (Class I recalls)
2 stories
Tagged Infectious disease and vaccines from the headline and teaser, so some stories may be missed or misfiled.
- FDA approvalDrugs@FDAOct 20, 2026FDA novel drug approval: Hibsago (Bepirovirsen Sodium), Glaxosmithkline
To treat chronic hepatitis B virus infection in certain adults without cirrhosis, in combination with existing antiviral therapy Priority review.
- FDA approvalDrugs@FDAOct 9, 2026FDA novel drug approval: Hovilpri (Pritelivir Mesylate), Aicuris Anti-Infect
To treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies Priority review.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.